GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (STU:TQ80) » Definitions » Cyclically Adjusted FCF per Share

Theratechnologies (STU:TQ80) Cyclically Adjusted FCF per Share : €-0.28 (As of Feb. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Theratechnologies Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Theratechnologies's adjusted free cash flow per share for the three months ended in Feb. 2025 was €-0.378. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.28 for the trailing ten years ended in Feb. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Theratechnologies was 35.40% per year. The lowest was -15.70% per year. And the median was 7.45% per year.

As of today (2025-04-25), Theratechnologies's current stock price is €2.40. Theratechnologies's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2025 was €-0.28. Theratechnologies's Cyclically Adjusted Price-to-FCF of today is .


Theratechnologies Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Theratechnologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Cyclically Adjusted FCF per Share Chart

Theratechnologies Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -0.32 -0.33 -0.30 -0.25

Theratechnologies Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.27 -0.25 -0.25 -0.28

Competitive Comparison of Theratechnologies's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Theratechnologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theratechnologies's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Cyclically Adjusted Price-to-FCF falls into.


;
;

Theratechnologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Theratechnologies's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Feb. 2025 (Change)*Current CPI (Feb. 2025)
=-0.378/128.7859*128.7859
=-0.378

Current CPI (Feb. 2025) = 128.7859.

Theratechnologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201505 0.052 100.263 0.067
201508 0.088 100.579 0.113
201511 0.130 100.421 0.167
201602 0.016 100.421 0.021
201605 -0.052 101.765 -0.066
201608 -0.025 101.686 -0.032
201611 0.109 101.607 0.138
201702 0.103 102.476 0.129
201705 -0.006 103.108 -0.007
201708 -0.071 103.108 -0.089
201711 0.069 103.740 0.086
201802 -0.013 104.688 -0.016
201805 -0.128 105.399 -0.156
201808 0.045 106.031 0.055
201811 0.100 105.478 0.122
201902 0.080 106.268 0.097
201905 -0.513 107.927 -0.612
201908 0.276 108.085 0.329
201911 -0.148 107.769 -0.177
202002 -0.230 108.559 -0.273
202005 -0.593 107.532 -0.710
202008 0.012 108.243 0.014
202011 -0.260 108.796 -0.308
202102 -0.205 109.745 -0.241
202105 -0.027 111.404 -0.031
202108 -0.028 112.668 -0.032
202111 -0.314 113.932 -0.355
202202 -0.212 115.986 -0.235
202205 -0.054 120.016 -0.058
202208 -0.140 120.569 -0.150
202211 -0.214 121.675 -0.227
202302 -0.137 122.070 -0.145
202305 -0.139 124.045 -0.144
202308 0.201 125.389 0.206
202311 -0.158 125.468 -0.162
202402 -0.032 125.468 -0.033
202405 -0.034 127.601 -0.034
202408 0.085 127.838 0.086
202411 -0.004 127.838 -0.004
202502 -0.378 128.786 -0.378

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Theratechnologies  (STU:TQ80) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Theratechnologies Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies Business Description

Industry
Traded in Other Exchanges
Address
2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Theratechnologies Headlines

No Headlines